Pseudomonas aeruginosa is an opportunistic Gram-negative bacterium, which is the etiological agent of chronic infections in immunocompromised patients [1] and in people affected by cystic fibrosis (CF) [2] . The treatment of the infections caused by this pathogen is very difficult due to its high intrinsic tolerance towards common antibiotics and the development of new resistant strains [3] . Consequently, novel therapeutic options are urgently needed for P. aeruginosa-related diseases. A potential approach could be targeting the quorum sensing (QS) which is a cell-to-cell communication system important for the regulation and coordination of the lifestyles of bacterial cells using diffusible small signal molecules [4] .
Introduction
Pseudomonas aeruginosa is an opportunistic Gram-negative bacterium, which is the etiological agent of chronic infections in immunocompromised patients [1] and in people affected by cystic fibrosis (CF) [2] . The treatment of the infections caused by this pathogen is very difficult due to its high intrinsic tolerance towards common antibiotics and the development of new resistant strains [3] . Consequently, novel therapeutic options are urgently needed for P. aeruginosa-related diseases. A potential approach could be targeting the quorum sensing (QS) which is a cell-to-cell communication system important for the regulation and coordination of the lifestyles of bacterial cells using diffusible small signal molecules [4] . length of the alkylene linker was varied for investigating its influence on PqsD inhibition (28 and 30). The propylene bridge present in 30 was favorable for inhibitor potency compared to 25 and 28 with a shorter linker (Table 1) . Methyl amide 34 was evaluated as an isostere of the corresponding ester 25. Both compounds displayed comparable activity with IC 50 s of 20 µM and 23 µM, respectively.
( Table 1, 2 columns) To date, we have identified two modes of action for reported PqsD inhibitors mainly differing in the binding site of a given compound [19 -21] . The addressed inhibitors either interacted directly with the active site residues or blocked the entrance of the enzyme substrate channel. To shed light on the binding mode of the novel compound class described herein, two specifically designed SPR experiments were performed following a protocol described by Weidel E. et al. [20] The first experiment deals with the analysis of binding between untreated PqsD and the compounds (Fig 2. A, Case I). The second SPR run was performed for evaluating the interactions between the protein, preincubated with ACoA, and the inhibitors (Fig 2. A, Case II). If the binding sites of the inhibitor and the anthraniloyl-PqsD adduct do not overlap similar association and dissociation curves should be observed for both SPR experiments (Fig 2.B) . The esters 9, 10, 11, 27, 30 and 36 were tested at 500µM and 250µM in both the assays. Considering the sensograms of the first experiment, all the α,β-unsaturated compounds 9, 10 and 11 did not disassociate completely ( Fig. 2.C, Fig S1. A). This may have two reasons: either these compounds possess a slow dissociation rate or they are covalent binders. On the contrary, 27, 30 and 36 were completely released by the enzyme (Fig. 2.D, Fig S1.B) . The evaluation of the results of the second assay revealed that all substances except 9 were able to bind the anthaniloyl-PqsD complex and showed a binding behavior similar to the first experiment (Fig 2, Fig S1) .
(Figure 2, 2 columns)
These data indicate that this compound class does not compete with ACoA upon binding to the enzyme.
Thus, it is more likely that these novel PqsD inhibitors interact with the upper region of the substrate tunnel behaving like channel-blockers as also observed for previously reported compounds [20 -21] . The determined response curves for compounds with the saturated linker were in accordance with the measured inhibitory potencies as 36 gave a higher response then 30 and 27. Hence, the combination of the phenyl ring on the ester moiety with the ethylene linker fits better in the channel of PqsD increasing, consequently, the affinity of the ligand towards the bacterial protein.
Selected compounds were also tested in a cell-based assay using a PA14 pqsH -mutant strain of
Pseudomonas aeruginosa at a final concentration of 250µM following a previously described protocol [15] (see Table 1 ). Among the tested compounds, the catechol derivatives possessing an ester moiety (11, 25, 26, 27, 28 and 30) were able to reduce the production of HHQ in the bacterial cultures without affecting cellular growth (Table   1 ). In contrast to the results of the cell-free assay, the olefin 11 performed better than its saturated analogue 25, while the methylene derivative 28 was slightly more potent than the longer linkers (25 and 30). The in cellulo activity is also influenced by the size of the ester moiety. While the methyl (25) , ethyl (26) and isopropyl (27) variants showed the same reduction of signal molecule, the bulky benzyl derivative did not exhibit inhibition HHQ production. Finally, while in the PqsD assay the ester 25 and the amide 34 were equally potent, the latter compound was completely inactive in the cell-based assay. These observations together with our recently reported study regarding a different class of PqsD inhibitors [23] emphasize the challenging task to develop in cellulo active QSI following a target-based approach. Nevertheless, considering the intrinsic low permeability of the outer membrane of P. aeruginosa [24] and the high efficiency of the efflux pumps, for example the MexAB-OprM complex [25] , the in cellulo activity of some compounds highlights that the scaffold has good properties for crossing the external barriers of Gram-negative bacteria. Further investigations are needed for increasing the in vitro and in cellulo potency.
Conclusions
Based on similarities between CHS2 and PqsD, the substrates of the former enzyme and their analogues were evaluated for their activity on the bacterial signal molecule synthase. This led to the discovery of a novel class of inhibitors possessing a catechol moiety as an essential motif for activity, connected to an ester moiety through an alkylene linker with at least two carbons. A structure activity relationship was derived resulting in compounds 27, 30 and 36 with promising inhibitory activities in the single-digit micromolar range. The binding mode of compounds possessing the saturated linker between the catechol and the ester moiety was investigated by SPR revealing that these inhibitors do not bind directly at the active site residues of PqsD, but more likely at the entrance of the substrate channel. In ongoing studies we are investigating a possible covalent mechanism of inhibition of this catechol-based class of compounds. Notably, several derivatives of this compound class were active in cellulo emphasizing favorable properties of the scaffold enabling the compounds to cross the Gramnegative outer membrane and to address cytoplasmic targets. Despite the inhibitory activity needs to be further optimized, the discovered scaffold has some potential for the development of novel anti-infectives for treating
Pseudomonas aeruginosa infections.
Experimental part

General
Starting materials were bought from Acros Organics, Sigma Aldrich and Alfa Aesar and were used without further purifications. Column chromatography was performed using silica gel 60 (63 -200µm) and the reactions were checked by TLC analysis using TLC Silica gel 60 F 254 (Merck) under UV light. Purification by semi-preparative HPLC was executed on an Agilent 1200 series HPLC system from Agilent Technologies using an Agilent C18 column (30x100mm/10µm) as stationary phase and a gradient of water and acetonitrile as eluent.
The purity of the compounds was checked by analytical HPLC using a SpectraSYSTEM (ThermoFisher) with a Macherey-Nagel C18 column (3x125mm/5µm) installed. Mass spectra (ESI) were measured on a Finnigan
Surveyor MSQ Plus (ThermoFisher). Mass spectra (EI) were measured on a DSQII instrument (ThermoFisher).
All compounds were obtained with a purity ≥95%. recorded on a Dionex Ultimate 3000 RSLC system using a Waters BEH C18, 50 x 2.1 mm, 1.7 µm dp column by injection of two µl methanolic sample. Separation was achieved by a linear gradient with (A) H2O + 0.1 % formic acid to (B) ACN + 0.1 % formic acid at a flow rate of 600 µL/min and 45 °C. The gradient was initiated by a 0.33 min isocratic step at 5 % B, followed by an increase to 95 % B in 9 min to end up with a 1 min flush step at 95 % B before reequilibration under the initial conditions. UV and MS detection were performed simultaneously.
Coupling the HPLC to the MS was supported by an Advion Triversa Nanomate nano-ESI system attached to a Thermo Scientific Orbitrap. Mass spectra were acquired in centroid mode ranging from 100 -1000 m/z or from 200 -2000 m/z at a resolution of R = 30000. The theoretical exact masses refer to the protonated species.
Synthesis
General procedure for the synthesis of compounds 9 -12 and 21 -29
After dissolving the carboxylic acid in the alcohol, three drops of H 2 SO 4 95% were added to the solution and the mixture was refluxed for 24h. The solvent was evaporated under reduced pressure and water was added to the crude mixture. The pH of the aqueous layer was adjusted to 7 adding drops of a saturated solution of NaHCO 3 and brine was added in the mixture. The aqueous layer was extracted three times with ethyl acetate; the organic layer was dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure yielding the final compound.
Further purification step was made when it was necessary. 
Methyl (E)-3-(4-hydroxyphenyl)acrylate (10
Isopropyl 3-(3,4-dihydroxyphenyl)
propanoate (27) . The carboxylic acid 17 (250 mg, 1.37 mmol) and iPrOH (25 ml) were used. 270 mg (88%) of yellow oil were obtained. 
Methyl 2-(3,4-dihydroxyphenyl)acetate (28
General synthesis of compounds 31 and 35
After dissolving the carboxylic acid in toluene (10 ml), SOCl 2 (1 ml) was added and the reaction mixture was refluxed. The toluene was removed under vacuum and the crude mixture was dissolved in CH 2 Cl 2 under N 2
atmosphere. The alcohol and Et 3 N were added together to the solution and the reaction mixture was stirred at room temperature for some hours. Brine was added to the mixture and, then, it was extracted three times with CH 2 Cl 2 ;
the organic layers were collected, dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure. 
Methyl 3-(benzo[d][1,3]dioxol-5-yl)propanoate (31)
.
Benzyl 3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)propanoate (35)
Synthesis of compound 33
3-(3,4-Bis((tert-butyldimethylsilyl)oxy)phenyl)-N-methylpropanamide (33
Synthesis of compounds 34 and 36
After dissolving the silyl ether compound in THF (4 ml), the solution was cooled with an ice-water bath.
HCl 1 N (1 ml) and TFA (0.5 ml) were added to the solution and the mixture was stirred at room temperature for 24h. Drops of saturated solution of NaHCO 3 were added to the mixture until the pH was adjusted to 7; brine was added to the mixture which was extracted three times with ethyl acetate. The organic layers were collected together, dried over Na 2 SO 4 and the solvent was evaporated under reduced pressure.
3-(3,4-Dihydroxyphenyl)-N-methylpropanamide (34)
. The silyl ether 33 (100 mg, 0.24 mmol) was used.
The crude extract was purified by column chromatography (pure ethyl acetate) yielding 36 mg (77%) of 34 as a colorless oil. 
Benzyl 3-(3,4-dihydroxyphenyl)propanoate (36
Biology
Expression and purification of recombinant PqsD
The procedure for expressing and purifying recombinant PqsD was conducted as recently described by us [15] . BL21 (λDE3) E. coli were transformed with the plasmid encoding PqsD (pT28b(+)/pqsD) and the expression of the protein was induced with IPTG overnight. After collecting the cells and lysis through sonication, the recombinant His 6 -tag PqsD was separated from the lysate via immobilized metal ion affinity chromatography (IMAC) followed by gel filtration. In the SPR experiments, His 6 -PqsD was used without cleaving the tag as previously reported [20] ; in the enzyme inhibition assay, protein without the histidine-tag was employed. The His 6 -tag was cleaved treating the His 6 -tag PqsD with thrombin and a second IMAC was run obtaining the purified protein.
Enzyme inhibition assay using recombinant PqsD
The IC 50 values were determined checking the enzyme activity by measuring the HHQ concentration as described in our previous work [16] . PqsD was incubated with the compound for 10 min before the addition of the substrates ACoA and β-ketodecanoic acid. The in-house PqsD inhibitor 4-(3-(N,N-diethylsulfamoyl)benzamido)-
'-dicarboxylic acid (IC 50 = 2.7 µM) published by Weidel et al. [20] was used as positive control.
All compounds were tested in sexduplicates.
Surface Plasmon Resonance
SPR experiments were carried out using a Reichert SR7500DC instrument optical biosensor (Reichert Technologies, Buffalo, NY, USA) and CMD500 M sensor chips obtained by XanTec (XanTec Bioanalytics, Düsseldorf, Germany). Processing and analysis of the data were performed using Scrubber software. Changes in refractive index due to DMSO-dependent solvent effects were corrected by use of a calibration curve (seven solutions, 4.25% -5.75% DMSO in buffer solutions).
The immobilization of His-tagged protein was performed following the procedure developed by Henn et al. [26] at 18 °C using standard amine coupling chemistry. H 6 -PqsD (38.4 kDa, >90% pure based on SDS PAGE) was immobilized at densities of 5521 µRIU for the binding affinity assay and 5959 µRIU for the binding studies with ACoA.
The binding assays were carried out using the protocol set up by Weidel et al. [20] with some modifications. At a constant flow rate of 30μl/min using instrument running buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 5% DMSO (v/v), 0.05% P-20 (v/v)), 9 -11, 27, 30 and 36 were tested at two concentrations, 500 µM and 250 µM. The compounds were injected consecutively employing 120 s of association and 300 s of dissociation. Experiments were performed twice. In the second experiment, ACoA (100 μM) was injected for 40 min with a constant flow of 5 μl/min to saturate the ACoA binding site. Afterwards, the flow rate was increased to 50 μl/min and kept stable for 30 min in order to flush all unreacted reagents and residue CoA away until reaching the stability of the baseline signal. The flow was decreased to 30 µl/min and additional ACoA (10 µM) was injected for 120 s association and 300 s dissociation to investigate if the binding site is fully blocked (no signal was observed). Then, the compounds (tested at 500 µM and 250 µM) were injected again for 120 s of association and 300 s of dissociation. The obtained binding signals in the equilibrium were compared to those obtained without ACoA pretreatment.
Experiments were performed twice.
Cultivation of P. aeruginosa PA14 pqsH -mutant
The cultivation of bacterial cells for the measurement of extracellular HHQ levels was set up following the protocol developed by Lépine et al. [27] 
